ChitogenX Inc C.CHGX

Alternate Symbol(s): CHNXF

Healthcare Biotechnology

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.

CSE:CHGX - Post by User

ChitogenX Inc

<< Previous

Bullboard Posts

Next >>

(41)
•••

Post by RockLobster1on Jan 06, 2021 7:35am

299 Views

Post# 32231057

global licensing agreement with Hanuman Pelican

PR Newswire

Provides Ortho RTI with worldwide rights to commercialize Buoy Suspension Fractional System in combination with Ortho-R
Provides Ortho RTI with Hanuman Buoy Suspension Fractional System for all US clinical sites participating in Ortho-R phase I / II clinical trial for rotator cuff tears repair

MONTREAL , Jan. 5, 2021 /PRNewswire/ - Ortho Regenerative Technologies Inc . (CSE: ORTH) (OTCQB: ORTIF) (" Ortho RTI " or the " Company "), a clinical stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today that it has entered into a global licensing agreement (the " Agreement ") with Hanuman Pelican Inc. (" Hanuman ") for the use of the Buoy Suspension Fractional System in combination with Ortho-R, Ortho RTI's lead Chitosan-PRP hybrid drug/biologic implant combination product.